Dare Bioscience (DARE) Share-based Compensation (2013 - 2025)

Dare Bioscience (DARE) has reported Share-based Compensation for 13 consecutive years, with $400000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Share-based Compensation fell 18.24% year-over-year to $400000.0; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (down 30.13% YoY), and the FY2025 full-year result was $1.5 million, down 32.07% from the prior year.
• Share-based Compensation eased to $400000.0 in Q4 2025 per DARE's latest filing, from $403027.0 in the prior quarter.
• Across five years, Share-based Compensation topped out at $1.0 million in Q1 2022 and bottomed at $26340.0 in Q2 2022.
• Historically, Share-based Compensation has averaged $501577.2 across 5 years, with a median of $464378.5 in 2021.
• The sharpest annual moves came in 2022 and 2023: Share-based Compensation plunged 93.5% in 2022, then surged 2368.44% in 2023.
• Over 5 years, Share-based Compensation stood at $388806.0 in 2021, then surged by 36.86% to $532133.0 in 2022, then grew by 16.47% to $619791.0 in 2023, then dropped by 21.06% to $489260.0 in 2024, then slipped by 18.24% to $400000.0 in 2025.
• According to Business Quant data, Share-based Compensation over the past three periods registered $400000.0, $403027.0, and $359018.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.